Antifungal Prophylaxis in Newly Diagnosed Acute Myeloid Leukemia Treated with a Hypomethylating Agent and Venetoclax: A Real-World Experience in Pharmacovigilance

被引：1
|
作者：
Burke, Mary [1 ]
Sallman, David A. [2 ]
Denson, Ariel [3 ]
Nelson, Rebecca Jean [3 ]
Chan, Onyee [4 ]
Walker, Alison R. [4 ]
Padron, Eric [4 ]
Xie, Zhuoer [4 ]
Komrokji, Rami S. [4 ]
Lancet, Jeffrey [4 ]
Kuykendall, Andrew T. [4 ]
Tobon, Katherine [3 ]
Jain, Akriti Gupta [1 ]
Wang, Chen [1 ]
Al Ali, Najla H. [1 ,4 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Pharm, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187206
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Survival and Prognosis Among 301 Patients with Newly-Diagnosed Acute Myeloid Leukemia Following Venetoclax Plus Hypomethylating Agent Therapy
    Karrar, Omer
    Iftikhar, Moazah
    McCullough, Kristen
    Johnson, Isla
    Abdelmagid, Maymona
    Al-Kali, Aref
    Alkhateeb, Hassan
    Begna, Kebede
    Mangaonkar, Abhishek A.
    Saliba, Antoine
    Hefazi, Mehrdad
    Litzow, Mark R.
    Hogan, William J.
    Shah, Mithun V.
    Patnaik, Mrinal M.
    Pardanani, Animesh D.
    Badar, Talha
    Murthy, Hemant S.
    Foran, James M.
    Palmer, Jeanne
    Sproat, Lisa
    Khera, Nandita
    Yi, Cecilia Y. Arana
    Tefferi, Ayalew
    Gangat, Naseema
    BLOOD, 2023, 142
  • [32] Real-world experience with hypomethylating agents and venetoclax as induction or salvage therapy followed by allogeneic stem cell transplantation in patients with acute myeloid leukemia
    Rautenberg, C.
    Stelljes, M.
    Acker, F.
    Holtick, U.
    Jost, E.
    Ragette, A.
    Kaivers, J.
    Tischer, J.
    Fraccaroli, A.
    Neuendor, N.
    Hanoun, M.
    Schmalbrock, L. K.
    Braitsch, K.
    Verbeek, M.
    Goetze, K.
    Bug, G.
    Reinhardt, C.
    Kroeger, N.
    Schroeder, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 193 - 193
  • [33] Real World Data on Clinical Outcomes of Newly Diagnosed Acute Myeloid Leukemia (AML) Patients Treated With Hypomethylating Agents (HMA) Plus Shorter Duration of Venetoclax (VEN) at a General Hospital
    Khan, Hina
    Yohannan, Binoy
    Cervoni-Curet, Frances
    Rios, Adan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S262 - S262
  • [34] Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis
    Weinbergerova, Barbora
    Mayer, Jiri
    Kabut, Tomas
    Sperr, Wolfgang R.
    Stevkova, Jana
    Jonasova, Anna
    Cernan, Martin
    Herndlhofer, Susanne
    Oravcova, Iveta
    Sramek, Jiri
    Novak, Jan
    Stepanova, Radka
    Szotkowski, Tomas
    Drgona, Lubos
    Zak, Pavel
    Valent, Peter
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 1746 - 1750
  • [35] A Real World Study of Venetoclax Combined with Azacitidine in 64 Chinese Patients Newly Diagnosed Acute Myeloid Leukemia
    Qian, Jiejing
    Xu, Jieyu
    Hong, Qing
    Lou, Yinjun
    Mao, Liping
    Xu, Weilai
    Yang, Min
    Yu, Wenjuan
    Meng, Haitao
    Mai, Wenyuan
    Ye, Xiujing
    Zhu, Honghu
    Jin, Jie
    BLOOD, 2021, 138
  • [36] Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia
    Maximilian Fleischmann
    Sebastian Scholl
    Jochen J. Frietsch
    Inken Hilgendorf
    Karin Schrenk
    Jakob Hammersen
    Florian Prims
    Christian Thiede
    Andreas Hochhaus
    Ulf Schnetzke
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 3191 - 3202
  • [37] Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia
    Fleischmann, Maximilian
    Scholl, Sebastian
    Frietsch, Jochen J.
    Hilgendorf, Inken
    Schrenk, Karin
    Hammersen, Jakob
    Prims, Florian
    Thiede, Christian
    Hochhaus, Andreas
    Schnetzke, Ulf
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (11) : 3191 - 3202
  • [38] REAL-WORLD TREATMENT PATTERNS AND COSTS IN MEDICARE BENEFICIARIES NEWLY DIAGNOSED WITH ACUTE MYELOID LEUKEMIA
    Stein, E. M.
    Latremouille-Viau, D.
    Guerin, A.
    Shi, S.
    Gagnon-Sanschagrin, P.
    Briggs, O.
    Bonifacio, G.
    Joseph, G.
    VALUE IN HEALTH, 2017, 20 (05) : A104 - A104
  • [39] Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia
    Gibson, Amber
    Dickson, Samantha
    McCall, David
    Garcia, Miriam
    Connors, Jeremy
    He, Jiasen
    Roth, Michael
    Nunez, Cesar
    Cuglievan, Branko
    PEDIATRIC BLOOD & CANCER, 2024,
  • [40] OUTCOMES OF RELAPSED OR REFRACTORY AND NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA AFTER HYPOMETHYLATING AGENT AND VENETOCLAX. THE ITALIAN REAL-LIFE EXPERIENCE BEFORE PUBLIC HEALTH REIMBURSEMENT (AVALON STUDY)
    Todisco, E.
    Papayannidis, C.
    Fracchiolla, N.
    Cerchione, C.
    Marconi, G.
    Petracci, E.
    Zingaretti, C.
    Vetro, C.
    Martelli, M. P.
    Zappasodi, P.
    Di Renzo, N.
    Cignetti, A.
    Lussana, F.
    Mattei, D.
    Ciceri, F.
    Facchini, L.
    Selleri, C.
    Fumagalli, M.
    Audisio, E.
    Griguolo, D.
    Basilico, C.
    Manfra, I.
    Borlenghi, E.
    Cairoli, R.
    Salutari, P.
    Gottardi, M.
    Molteni, A.
    Martini, V.
    Lunghi, M.
    Fianchi, L.
    Cilloni, D.
    Lanza, F.
    Abruzzese, E.
    Cascavilla, N.
    Rivellini, F.
    Ferrara, F.
    Maurillo, L.
    Nanni, J.
    Romano, A.
    Cardinali, V.
    Gigli, F.
    Vincenzo, F.
    Volpi, R.
    Sciume, M.
    Tarella, C.
    Rossi, G.
    Martinelli, G.
    HAEMATOLOGICA, 2021, 106 (10) : 15 - 16
12345